Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
New insights into acquired endocrine resistance of breast cancer
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
Dual-mechanism estrogen receptor inhibitors | PNAS
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α* - Journal of Biological Chemistry
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
